The process of developing and bringing a drug to market is long and expensive, and from test tube to pharmacy, the competition for resources – including clinical trial participant and investor resources – is fierce. To...more
In late May, the FDA released a draft guidance document detailing its best practices for developing trademarks for drugs. The draft guidance, entitled Best Practices in Developing Proprietary Names for Drugs, can be found...more
In This Issue:
- FDA Draft Guidance: Best Practices for Developing Drug Trademarks
- U.S. Patent and Trademark Office Proposes Fee Reductions
- gTLD Sunrise Periods Now Open
- Excerpt from U.S. Patent and...more